Found 6 matching trials
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
PHASE1The purpose of this study is to test a new way of treating the most common ...
Location
Albert Einstein College of Medicine
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
PHASE1This is a study to determine the maximum tolerated dose (MTD) for CDX-1140 ...
Location
HonorHealth Research Insititute
FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer
PHASE2Based on promising data from our laboratory demonstrating synergy between a...
Location
Montefiore Medical Center
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
PHASE1This phase I trial evaluates the safety and effectiveness of in situ immuno...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma
PHASE2This phase II trial studies the effect of a vaccine called CDX-1401 given w...
Location
University of Chicago Comprehensive Cancer Center
Vaccination With Flt3L, Radiation, and Poly-ICLC
PHASE1This is a combination of 4 therapies, three of which are used to treat a si...
Location
Icahn School of Medicine at Mount Sinai